Author: Talia Ogliore

WashU Medicine researchers identified key details of how DNA damage can flip a nerve cell’s self-destruct switch. The new study could lead to novel routes to preventing neurodegeneration in a variety of diseases.

Andrew K. Groves, a renowned developmental biologist known for his research into inner ear development and hearing loss with a focus on the potential for hearing restoration, has been named the inaugural Stuart A. Kornfeld Distinguished Professor of Medical Sciences at WashU Medicine.

Matthew R. Rosengart, MD, a leading expert on sepsis and circadian rhythms whose research has improved care and outcomes for vulnerable patients, has been installed as the inaugural Theodore and Bertha Bryan Professor of Environmental Medicine in the WashU Medicine Mary Culver Department of Surgery.

At the WashU Office of Technology Management’s annual Celebration of Inventors, WashU Medicine researchers Graham Colditz and Shu (Joy) Jiang were honored for developing and commercializing a technology to predict breast cancer risk.

Four physician-scientists have been selected as Dean’s Scholars. The WashU Medicine program supports outstanding early-career faculty at WashU Medicine who bridge the gap between research and clinical care.

The discovery by WashU Medicine scientists and their collaborators could lead to a single vaccine against E. coli, Shigella and other causes of severe diarrhea.

Conrad C. Weihl, MD, PhD, a leading expert in the genetic mechanisms of neuromuscular disorders such as muscular dystrophy, has been installed as the inaugural Gabe Weil Professor in the Department of Neurology at WashU Medicine.

Nicholas O. Davidson, MD, DSc, chief of the Division of Gastroenterology at WashU Medicine, has been honored with the 2026 Distinguished Mentor Award from the American Gastroenterological Association.

WashU Medicine researchers have found that the shot from Moderna, currently under review by the FDA, could provide stronger and longer-lasting protection than the standard flu shot.

A WashU Medicine researcher has received a $3.5 million grant from the National Institute on Drug Abuse to study long-term neurodevelopmental outcomes in mice exposed to oxycodone before birth.